🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, non-randomized, two-period, cross-over, mass balance...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-08
Trial ID
NCT02000765
Treatments Being Tested
This study is divided in 2 parts. Part 1a is being conducted to evaluate th...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-04
Trial ID
NCT02853435
Treatments Being Tested
This study will be conducted in three parts (Part 1, Part 2 and Part 3). Pa...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-01-28
Trial ID
NCT02045849
Treatments Being Tested
GSK2140944 has demonstrated in vitro activity against Neisseria (N.) gonorr...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-15
Trial ID
NCT02294682
Treatments Being Tested
Gepotidacin is a new antibiotic that may potentially be used to treat prost...
Status
Completed
Location
MUVienna
Start Date
2021-01-29
Trial ID
NCT04484740
Treatments Being Tested
The study will be conducted to evaluate how a single oral dose of Gepotidac...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-29
Trial ID
NCT07371429
Treatments Being Tested
This is double-blind, randomized, sequential, two part study. Part 1 is a 3...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-09-04
Trial ID
NCT04079790
Treatments Being Tested
Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II ...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-23
Trial ID
NCT03568942
Treatments Being Tested
This is a phase III, randomized, multicenter, open-label study which will b...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-10-21
Trial ID
NCT04010539
Treatments Being Tested
This study is a randomized, open-label, two periods, cross-over pharmacokin...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-03-01
Trial ID
NCT05271799
Treatments Being Tested